Imagine a day when a urine test could inform a doctor precisely why a kidney transplant patient was experiencing organ rejection and suggest the best medication for specifically addressing the problem.
New Study Uncovers Transplant Rejection Insights, Targets New Drug Development miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Research reveals novel insights into transplant rejection and new drug development targets medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
New Delhi [India], March 15 (ANI/NewsVoir): Dr Lal PathLabs Limited, one of India's leading pathology diagnostic providers with more than 250 laboratories and 4500 sample collection points, has appointed Kyndryl (NYSE: KD), the world's largest IT infrastructure services provider, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers. Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms that play a key role in Dr Lal PathLabs' digital transformation initiatives to drive business growth. Kyndryl provides a single pane view of server utilization, service requests, ticketing lifecycle, incident analysis, and also recommends proactive remediation. Offering a unified view of their infrastructure utilization on-premises and across multiple public cloud environments has improved service availability and helped Dr Lal Pathlabs reduce IT incid